Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.54 |
| ▸ | CYP19A1 known ✓ | P11511 | 3/20 | 0.53 |
| ▸ | GABRP known ✓ | O00591 | 1/20 | 0.52 |
| ▸ | GABRD known ✓ | O14764 | 1/20 | 0.52 |
| ▸ | GABRA1 known ✓ | P14867 | 1/20 | 0.52 |
| ▸ | GABRB1 known ✓ | P18505 | 1/20 | 0.52 |
| ▸ | GABRG2 known ✓ | P18507 | 1/20 | 0.52 |
| ▸ | GABRB3 known ✓ | P28472 | 1/20 | 0.52 |
| ▸ | GABRA5 known ✓ | P31644 | 1/20 | 0.52 |
| ▸ | GABRA3 known ✓ | P34903 | 1/20 | 0.52 |
| ▸ | GABRA2 known ✓ | P47869 | 1/20 | 0.52 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.52 |
| ▸ | GABRA4 known ✓ | P48169 | 1/20 | 0.52 |
| ▸ | GABRE known ✓ | P78334 | 1/20 | 0.52 |
| ▸ | GABRA6 known ✓ | Q16445 | 1/20 | 0.52 |
| ▸ | GABRG1 known ✓ | Q8N1C3 | 1/20 | 0.52 |
| ▸ | GABRG3 known ✓ | Q99928 | 1/20 | 0.52 |
| ▸ | GABRQ known ✓ | Q9UN88 | 1/20 | 0.52 |
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.52 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11097357 | 1.00 | AKR1B1 (0.58) | AKR1B1NAPRTCA2CAMK2ACYP19A1 | |
| Hydrochloric Acid SCHEMBL28071881 | 0.98 | AKR1B1 (0.56) | AKR1B1NAPRTCA2CAMK2ACYP19A1 | |
| SCHEMBL48554 | 0.98 | AKR1B1 (0.61) | AKR1B1NAPRTCA2CAMK2ACYP19A1 | |
| SCHEMBL987989 | 0.95 | AKR1B1 (0.58) | AKR1B1NAPRTCA2CAMK2ACYP19A1 | |
| SCHEMBL26114653 | 0.95 | AKR1B1 (0.58) | AKR1B1NAPRTCA2CAMK2ACYP19A1 | |
| Phenylacetic Acid SCHEMBL8733324 | 0.94 | AKR1B1 (0.71) | AKR1B1NAPRTCA2CAMK2ACYP19A1 | |
| Hydrochloric Acid SCHEMBL8073173 | 0.85 | NAPRT (0.83) | AKR1B1NAPRTCYP19A1ALDH1A1GAA | |
| SCHEMBL5149062 | 0.85 | ABCC4 (0.67) | AKR1B1NAPRTCA2CAMK2AGAA | |
| Phenylacetic Acid SCHEMBL8586416 | 0.82 | AKR1B1 (0.74) | AKR1B1NAPRTCA2CAMK2ACYP19A1 | |
| Hydrochloric Acid SCHEMBL25180348 | 0.82 | CA2 (0.75) | AKR1B1CA2CAMK2AGABRPGABRD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 655 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114479769-B | Preparation method of silica-coated paraffin phase-change nano microcapsule | 山东绿拓涂料科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-114479769-A | Preparation method of silicon dioxide-coated paraffin phase-change nano microcapsule | 山东绿拓涂料科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-112185606-B | High-molecular flexible conductive film and preparation method thereof | 深圳市法鑫忠信新材料有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-112185606-A | High-molecular flexible conductive film and preparation method thereof | 梁燕 | 2021-01-05 | — | — | CN | claimed |
| CN-104785302-B | Denitrifying catalyst with selective catalytic reduction and its preparation method and application | 北京大学包头创新研究院 | 2019-05-10 | — | — | CN | claimed |
| CN-106117076-B | A kind of novel toluylene derivative and preparation method thereof | 北京理工大学 | 2018-11-06 | — | — | CN | claimed |
| CN-108276376-A | Novel two allyl benzene derivatives of one kind and preparation method thereof, a kind of pharmaceutical composition | 北京理工大学 | 2018-07-13 | — | — | CN | claimed |
| CN-106117076-A | A kind of novel toluylene derivant and preparation method thereof | 北京理工大学 | 2016-11-16 | — | — | CN | claimed |
| CN-104785302-A | Selective catalytic reduction denitration catalyst, preparation method and application thereof | BAOTOU INST OF INNOVATION PEKING UNIVERSITY | 2015-07-22 | — | — | CN | claimed |
| CN-103113427-B | Fructosevaline preparation method | NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO LTD | 2015-04-08 | — | — | CN | claimed |
| CN-103113427-A | Fructosevaline preparation method | NINGBO MEDICAL BIOLOG TECHNOLOGY CO LTD | 2013-05-22 | — | — | CN | claimed |
| US-7109377-B2 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2006-09-19 | — | — | US | claimed |
| EP-1021528-B1 | METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS | INST GENETICS LLC (US) | 2004-01-28 | — | — | EP | claimed |
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-05-01 | — | — | US | claimed |
| US-6448443-B1 | GENERATED FROM DIVERSIFIABLE SCAFFOLDS SYNTHESIZED FROM THE PYRIDINE-BASED TEMPLATE ISONICOTINAMIDE; ALSO PROVIDES A NOVEL ORTHO-NITROBENZYL PHOTOLINKER; SYNTHESIZED FROM A SHIKIMIC ACID BASED EPOXYOL TEMPLATE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2002-09-10 | — | — | US | claimed |
| US-20020052026-A1 | METHODS OF REFOLDING PROTEINS | GENETICS INSTITUTE, LLC | 2002-05-02 | — | — | US | claimed |
| EP-1021528-A1 | METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS | GENETICS INSTITUTE, INC. (US) | 2000-07-26 | — | — | EP | claimed |
| WO-2000006525-A9 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | HARVARD COLLEGE (US) | 2000-04-20 | — | — | WO | claimed |
| WO-2000006525-A2 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-10 | — | — | WO | claimed |
| WO-1999018196-A1 | METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS | GENETICS INSTITUTE, INC. (US) | 1999-04-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | TKFC, NISCH, PTGIS | CA2 3194/4885CYP19A1 515/4885GABRP 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.